SecBot SecBot
25-NSE ·Filed Jul 13, 2026

CERO

CERO THERAPEUTICS HOLDINGS, INC.
BEARISH
Impact 7/10
Horizonimmediate Processed4mo ago SEC0001354457-26-000670
Actionable Insight ▼ Bearish

The delisting is now irrevocable. Expect continued deterioration in liquidity and possible SEC deregistration (Form 15) which would halt public reporting. Existing OTC holders face minimal catalyst for recovery unless the company announces a business combination or reverse merger, unlikely given the sustained non-compliance.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.0150
T+0 close · Jul 13, 2026 · via day close
Latest settled
−40.00%
T+60 · $0.009000
Vs SPY
−44.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 13 $0.0150entry
  2. T+1 · 4mo ago −13.33%α −13.69% · $0.0130
  3. T+5 · 4mo ago −27.33%α −26.39% · $0.0109
  4. T+20 · 3mo ago −33.33%α −36.52% · $0.0100
  5. T+60 · 6w ago −40.00%α −44.25% · $0.009000

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nasdaq has filed a Form 25-NSE to formally remove CERO Therapeutics' securities from listing and registration, effective July 23, 2026, after the company failed to meet continued listing requirements under Rule 5550(b)(1) and exhausted all appeals through Nasdaq's hearing and review process. The company's securities have been suspended since October 31, 2025, and this filing makes the delisting final, further reducing liquidity and likely pushing the stock deeper into OTC territory.

Key Facts

  • Delisting effective at the opening of trading on July 23, 2026
  • Nasdaq Staff determined the company no longer met Listing Rule 5550(b)(1) (equity/market cap/income requirements)
  • Securities have been suspended since October 31, 2025
  • All appeals, Panel, NLHRC, and Board of Directors, were exhausted; final action letter issued February 6, 2026
  • Securities include common stock and warrants

Financial Impact

Delisting from Nasdaq eliminates exchange-traded liquidity, likely triggering further price erosion and potential default covenants; no specific dollar amounts in the filing.

liquiditytrading venueinvestor access

Risk Factors

  • Further loss of liquidity as institutional holders exit OTC positions
  • Risk of SEC deregistration, ending public reporting obligations
  • Potential acceleration of debt or other contractual obligations tied to Nasdaq listing
  • No visible operational catalyst to reverse the decline

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (CERO), Batch item 10001354457-26-000670
Document: 0001354457-26-000670-index-headers.html0001354457-26-000670
Document: 0001354457-26-000670-index.html0001354457-26-000670
Document: 0001354457-26-000670.txt0001354457-26-000670
25-NSE Filing (CERO), Batch item 50001354457-26-000670
Document: 0001354457-26-000670-index-headers.html0001354457-26-000670
Document: 0001354457-26-000670-index.html0001354457-26-000670
Document: 0001354457-26-000670.txt0001354457-26-000670

Track record

5 reports on CERO

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +65.71% at T+60 after the Mar 11, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Oct 7, 20265w ago 8-K Bearish 6/10 Entry $0.0951 Now $0.005000 +94.74% No price data
  2. Aug 31, 202611w ago 8-K Bearish 7/10 Entry $0.0120 to $0.0105 Now $0.005000 +58.33% ▲ +12.50% +13.68% vs SPY
  3. Jul 13, 202618w ago 25-NSE Bearish 7/10 Viewing Entry $0.0150 to $0.0100 Now $0.005000 +66.67% ▲ +33.33% +36.52% vs SPY
  4. Jun 26, 202620w ago 8-K Bearish 6/10 Entry $0.0110 to $0.009700 Now $0.005000 +54.55% ▲ +11.82% +11.56% vs SPY
  5. Mar 11, 202635w ago 8-K Bearish 7/10 Entry $0.0350 to $0.0340 Now $0.005000 +85.71% ▲ +2.86% +3.38% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens in 5h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 13, 2026